NO165922C - Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.

Info

Publication number
NO165922C
NO165922C NO874550A NO874550A NO165922C NO 165922 C NO165922 C NO 165922C NO 874550 A NO874550 A NO 874550A NO 874550 A NO874550 A NO 874550A NO 165922 C NO165922 C NO 165922C
Authority
NO
Norway
Prior art keywords
quinolizin
methano
hexahydro
hydroxy
preparation
Prior art date
Application number
NO874550A
Other languages
English (en)
Norwegian (no)
Other versions
NO874550L (no
NO874550D0 (no
NO165922B (no
Inventor
Maurice Ward Gittos
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO874550D0 publication Critical patent/NO874550D0/no
Publication of NO874550L publication Critical patent/NO874550L/no
Publication of NO165922B publication Critical patent/NO165922B/no
Publication of NO165922C publication Critical patent/NO165922C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO874550A 1986-11-03 1987-11-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser. NO165922C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92661986A 1986-11-03 1986-11-03

Publications (4)

Publication Number Publication Date
NO874550D0 NO874550D0 (no) 1987-11-02
NO874550L NO874550L (no) 1988-05-04
NO165922B NO165922B (no) 1991-01-21
NO165922C true NO165922C (no) 1991-05-02

Family

ID=25453460

Family Applications (2)

Application Number Title Priority Date Filing Date
NO874550A NO165922C (no) 1986-11-03 1987-11-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO1999020C NO1999020I1 (no) 1986-11-03 1999-08-26 Dolasetron

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1999020C NO1999020I1 (no) 1986-11-03 1999-08-26 Dolasetron

Country Status (21)

Country Link
EP (1) EP0266730B1 (fr)
JP (2) JP2542225B2 (fr)
KR (1) KR950011737B1 (fr)
CN (1) CN1021654C (fr)
AR (1) AR246264A1 (fr)
AT (1) ATE109779T1 (fr)
AU (1) AU600318B2 (fr)
CA (1) CA1329203C (fr)
DE (2) DE3750359T2 (fr)
DK (1) DK171116B1 (fr)
ES (1) ES2061469T3 (fr)
FI (1) FI87786C (fr)
HU (1) HU197008B (fr)
IE (1) IE63670B1 (fr)
IL (1) IL84309A (fr)
NL (1) NL970043I2 (fr)
NO (2) NO165922C (fr)
NZ (1) NZ222349A (fr)
PH (2) PH24664A (fr)
PT (1) PT86060B (fr)
ZA (1) ZA878096B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0329902A1 (fr) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Utilisation des dérivés de la quinolizinone et de la quinolizine pour la manufacture des médicaments pour le traitement de la psychose
EP0329932B1 (fr) * 1988-02-23 1995-10-18 Merrell Pharmaceuticals Inc. Utilisation des dérivés de la quinolizine et de la quinolizinone pour la manufacture des médicaments
EP0329904A1 (fr) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Utilisation des dérivés de la quinolizine et de la quinolizinone dans la manufacture des médicaments pour le traitement de l'anxiété
EP0329903A1 (fr) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Utilisation des dérivés de quinolizinone et de la quinolizine pour la manufacture des médicaments pour le traitement du glaucome
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
EP0329905A1 (fr) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Utilisation des dérivés de la quinolizine et de la quinolizinone pour la manufacture des médicaments pour l'augmentation de la motilité gastrique
EP0330788A1 (fr) * 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Utilisation des dérivés de la quinolizine et de la quinolizinone pour la manufacture des médicaments pour le traitement de l'arythmie cardiaque
ZA893008B (en) * 1988-04-29 1989-12-27 Merrell Dow Pharma Process for preparing indole-3-carboxylic acid esters of transhexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
EP0492020A1 (fr) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Utilisation de certains esters de la hexahydro-8-hydroxy-2,6-méthano-2H-quinolizine-3(4H)-one et des composés apparentés pour le traitement des maladies cognitives
BR9813480A (pt) * 1997-12-17 2000-10-10 Biocryst Pharm Inc Compostos inibidores de neuraminidase de ciclopentano substituìdo, composição e métodos de inibição da neuraminidase do vìrus da influenza- e de tratamento de infecção por vìrus da influenza-
CN100390172C (zh) * 2004-09-10 2008-05-28 成都欣捷高新技术开发有限公司 一种甲磺酸多拉司琼晶型及其制备方法
EP1819705A1 (fr) * 2004-11-25 2007-08-22 Cilag Ltd. Procede pour preparer des esters d'hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-one
EP1904492B1 (fr) * 2005-07-06 2008-10-15 Inke, S.A. Procédé servant à obtenir le composé actif du point de vue pharmaceutique dolasetron, intermédiaires de synthèse de celui-ci et procédés servant à obtenir ceux-ci
ES2264901B1 (es) 2005-07-06 2007-12-01 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimiento para la obtencion de los mismos.
US20070203176A1 (en) * 2006-01-05 2007-08-30 Janos Hajko Crystalline forms of dolasetron base and processes for preparation thereof
EP2060557B1 (fr) 2007-11-13 2012-06-06 Inke, S.A. Composés intermédiaires utiles pour préparer du dolasetron
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
JP5955767B2 (ja) 2009-05-20 2016-07-20 インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） 損傷性前庭障害の処置における使用のためのセロトニン５−ｈｔ３受容体拮抗薬
US20180250270A1 (en) 2015-09-11 2018-09-06 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
CN108976230A (zh) * 2018-06-18 2018-12-11 东莞市联洲知识产权运营管理有限公司 一种基于石墨烯活化制备甲磺酸多拉司琼关键中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
DE3587151T2 (de) * 1984-12-20 1993-07-15 Sandoz Ag Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.

Also Published As

Publication number Publication date
FI874768A (fi) 1988-05-04
EP0266730B1 (fr) 1994-08-10
PH26261A (en) 1992-04-01
DE3750359T2 (de) 1994-12-08
JP2542225B2 (ja) 1996-10-09
IE872955L (en) 1988-05-03
DE3750359D1 (de) 1994-09-15
NO874550L (no) 1988-05-04
FI87786C (fi) 1993-02-25
PT86060B (pt) 1990-07-31
JP2657267B2 (ja) 1997-09-24
KR880006240A (ko) 1988-07-22
AR246264A1 (es) 1994-07-29
FI87786B (fi) 1992-11-13
ATE109779T1 (de) 1994-08-15
DK572887D0 (da) 1987-11-02
ES2061469T3 (es) 1994-12-16
AU8059687A (en) 1988-05-05
NO874550D0 (no) 1987-11-02
NL970043I1 (nl) 1998-03-02
CA1329203C (fr) 1994-05-03
NZ222349A (en) 1990-05-28
CN87107629A (zh) 1988-06-15
NO1999020I1 (no) 1999-08-26
NL970043I2 (nl) 1998-10-01
AU600318B2 (en) 1990-08-09
IE63670B1 (en) 1995-05-31
IL84309A (en) 1991-09-16
JPS63258476A (ja) 1988-10-25
JPH0977769A (ja) 1997-03-25
FI874768A0 (fi) 1987-10-29
DK572887A (da) 1988-05-04
KR950011737B1 (ko) 1995-10-09
PT86060A (en) 1987-12-01
EP0266730A1 (fr) 1988-05-11
DK171116B1 (da) 1996-06-17
HU197008B (en) 1989-02-28
ZA878096B (en) 1988-04-26
PH24664A (en) 1990-09-07
NO165922B (no) 1991-01-21
HUT45055A (en) 1988-05-30
DE19775092I2 (de) 2001-11-22
CN1021654C (zh) 1993-07-21

Similar Documents

Publication Publication Date Title
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO165344C (no) Analogifremgangsmaate for fremstilling av teraputisk aktive indolizin-derivater.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.

Legal Events

Date Code Title Description
MK1K Patent expired
MK1K Patent expired